Operating Expenses Changement
Acadia Pharmaceuticals ACAD:US $ 168.21M 60.27M
Agios Pharmaceuticals AGIO:US $ 100.52M 1.24M
Akebia Therapeutics AKBA:US $ 74.26M 45.93M
ALKERMES ALKS:US 310.68M 5.55M
Alnylam Pharmaceuticals ALNY:US $ 416.5M 56.51M
Amgen AMGN:US $ 4.42B 680M
Biogen BIIB:US $ 2648.2M 727.1M
Biomarin Pharmaceutical BMRN:US $ 494.65M 112.61M
Bluebird Bio BLUE:US $ 108.92M 13.37M
Exelixis EXEL:US $ 335.72M 62.98M
Intercept Pharmaceuticals ICPT:US $ 85.12M 13.73M
Intra Cellular Therapies ITCI:US $ 143.5M 35.84M
IONIS PHARMACEUT IONS:US $ 219.3M 19.88M
Macrogenics MGNX:US $ 67.82M 9.92M
Nektar Therapeutics NKTR:US $ 174.42M 33.04M
Neurocrine Biosciences NBIX:US $ 393.5M 86M
Prothena PRTA:US 44.52M 5.42M
Regeneron Pharmaceuticals REGN:US $ 1747.3M 40.7M
Seattle Genetics SGEN:US $ 630.61M 71.1M
Ultragenyx Pharmaceutical RARE:US $ 230.94M 14.37M
Vertex Pharmaceuticals VRTX:US $ 1089.9M 33.3M
Vital Therapies VTL:US $ 20.61M 825K
Xoma XOMA:US $ 5.75M 578K
YTE INCY:US $ 656.97M 40.27M



Prothena Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Sep 2022.